Editorial role
Expertise
Molecular genomics
Selected publications
- Rafeeq MM, Alghamdi S, Qasem AH, Almehmadi SJ, Al-Moraya IS, Alkathiri A, Almotairi RM, Alam Q (2023). Curcumin as a potent inhibitor molecule for mixed lineage kinase: a molecular docking and in vitro study for potential cancer treatment Curcumin as a potent inhibitor molecule for mixed lineage kinase: a molecular docking and in vitro study for potential. Bioscience Research; 20(2): 549-556.
- 2. Alzahrani A, Kamal MA, Akber AH, Asiri AA, Shafei MI, Ghawi MH, Alotaibi HM, Alam Q (2023). Molecular docking analysis of EGFRinhibitors for breast cancer management. Bioinformation; 19(6): 707-712.
- 3. Umair M, Afsar T, Khan H, Ali Z, Zehri Z, Zaman G, Hussain A, Zeb S, Alam Q; Razak S (2023). Variant in LRR Domain of SLITRK2 Underlying X-linked Neurodevelopmental Disorders. Journal of Gene Medicine (Submitted). I.F. 3.5
- 4. Alghamdi S, Baeissa HM, Kamal MA, Rafeeq MM, Al Zahrani A, Maslum AA, Hakeem IJ, Alzragi RS, Alam Q (2023). Unveiling the multitargeted potency of Sodium Danshensu against Cervical Cancer: A Multitargeted Docking-based, Structural Fingerprinting and Molecular Dynamics Simulation Study. Journal of Biomolecular Structure and Dynamics. doi: 10.1080/07391102.2023.2248260I.F. 4.5
- 5. Umair Muhamma; Afsar, Tayyaba; Khan, Hammal; Ali, Zain; Zehri, Zamrud; Zaman,
- Gohar; Hussain, Amir; Zeb, Shah; Alam, Qamre; Razak, Suhail (2023). Variant in LRR
- Domain of SLITRK2 Underlying X-linked Neurodevelopmental Disorder. Journal of Gene
- Medicine. (Under Review) I.F. 3.5